Ontology highlight
ABSTRACT: Background
Classical Hodgkin's lymphoma (cHL) in adolescents between 15 and 18 years old shows a higher disease-related mortality, and the overall prognosis is worse than in both children and adults.Objectives
We investigated the immune checkpoint inhibitors (ICPIs) therapeutic targets and specific T-regulatory and cytotoxic T-cell subsets in the subgroup of adolescent cHL patients, and we challenged their prognostic power.Methods
We retrieved formalin-fixed paraffin-embedded (FFPE) tissue of adolescent patients diagnosed with cHL and tested by immunohistochemistry the immune checkpoint molecules CTLA-4, LAG-3, PD-1, and PDL1 as well as the biological markers FOXP3 and CD8.Results
All the cases of our cohort expressed the immune checkpoint molecules CTLA-4,
SUBMITTER: Bertuzzi C
PROVIDER: S-EPMC11674618 | biostudies-literature | 2024 Dec
REPOSITORIES: biostudies-literature